Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
101.35
-3.65 (-3.48%)
At close: May 8, 2026, 4:00 PM EDT
103.00
+1.65 (1.63%)
After-hours: May 8, 2026, 7:58 PM EDT
Insmed Stock Forecast
Stock Price Forecast
The 23 analysts that cover Insmed stock have a consensus rating of "Strong Buy" and an average price target of $200.17, which forecasts a 97.50% increase in the stock price over the next year. The lowest target is $120 and the highest is $245.
Price Target: $200.17 (+97.50%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 12 | 12 | 13 | 13 | 13 |
| Buy | 9 | 10 | 9 | 10 | 10 | 10 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 24 | 23 | 24 | 24 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $220 → $205 | Buy | Maintains | $220 → $205 | +102.27% | May 8, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $177 → $160 | Buy | Maintains | $177 → $160 | +57.87% | May 8, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $230 → $226 | Strong Buy | Maintains | $230 → $226 | +122.99% | May 8, 2026 |
| Roth Capital | Roth Capital | Strong Buy Reiterates $212 | Strong Buy | Reiterates | $212 | +109.18% | Apr 17, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $212 → $216 | Buy | Maintains | $212 → $216 | +113.12% | Apr 14, 2026 |
Financial Forecast
Revenue This Year
1.72B
from 606.42M
Increased by 183.63%
Revenue Next Year
2.88B
from 1.72B
Increased by 67.67%
EPS This Year
-2.81
from -6.42
EPS Next Year
0.96
from -2.81
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 2.3B | 3.8B | ||||||
| Avg | 1.7B | 2.9B | ||||||
| Low | 949.6M | 2.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 282.2% | 119.4% | ||||||
| Avg | 183.6% | 67.7% | ||||||
| Low | 56.6% | 19.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.29 | 2.56 | ||||||
| Avg | -2.81 | 0.96 | ||||||
| Low | -5.02 | -0.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.